Lithocholic acid inhibits dendritic cell activation by reducing intracellular glutathione via TGR5 signaling

Dendritic cells (DCs) are the major antigen-presenting cells and play an important role in autoimmune uveitis. Emerging evidence suggests that bile acids (BAs) regulate DCs maturation. However, the underlying mechanisms by which BAs regulate the function of DCs still need to be clarified. Here, we demonstrate that lithocholic acid (LCA) inhibits the production of pro-inflammatory cytokines and the expression of surface molecules in bone marrow-derived dendritic cells (BMDCs). LCA attenuates the severity of EAU by modulating the maturation of splenic CD11C⁺MHCII^high DCs. Notably, Takeda G-protein coupled receptor 5 (TGR5) deficiency partially reverses the inhibitory effect of LCA on DCs in vitro and in vivo. TGR5 activation also downregulates the NF-κB and MAPK pathways by inhibiting glutathione production and inducing oxidative stress in DCs, which leads to apoptosis and autophagy in DCs. In addition, LCA or INT-777 treatment increases the TGR5 expression in monocyte-derived dendritic cells (MD-DCs) of patients with active BD, whereas both LCA and TGR5 agonists inhibit the activation of MD-DCs. These results suggest that LCA and TGR5 agonists might be potential therapeutic drugs for the treatment of autoimmune uveitis.     

Design,synthesis, and biological evaluation of novel carbazole derivatives as potent DNMT1 inhibitors with reasonable PK properties

The DNA methyltransferases (DNMTs) were found in mammals to maintain DNA methylation. Among them, DNMT1 was the first identified, and it is an attractive target for tumour chemotherapy. DC_05 and DC_517 have been reported in our previous work, which is non-nucleoside DNMT1 inhibitor with low micromolar IC₅₀ values and significant selectivity towards other S-adenosyl-_L-methionine (SAM)-dependent protein methyltransferases. In this study, through a process of similarity-based analog searching, a series of DNMT1 inhibitors were designed, synthesized, and evaluated as anticancer agents. SAR studies were conducted based on enzymatic assays. And most of the compounds showed strong inhibitory activity on human DNMT1, especially WK-23 displayed a good inhibitory effect on human DNMT1 with an IC₅₀ value of 5.0 µM. Importantly, the pharmacokinetic (PK) profile of WK-23 was obtained with quite satisfying oral bioavailability and elimination half-life. Taken together, WK-23 is worth developing as DNMT1-selective therapy for the treatment of malignant tumour.     

银合欢基因文库的构建和种子贮藏蛋白基因的分离

本文以λEMBL_3为载体,构建了银合欢(Leucaena leucocephala)的基因文库,所得重组子为3.5×10~6pfu。以大豆种子贮藏蛋白α′亚基基因为探针,从基因文库中分离得到了4个阳性克隆,并初步绘制了其中3个重组子的物理图谱。结果表明在这3个重组子的基因内部有一致的酶切位点。亚克隆的部分核苷酸序列与 GenBank 中的基因序列比较,表明与大豆种子贮藏蛋白α′亚基基因高度同源。     

A new technique to expand human mesenchymal stem cells using basement membrane extracellular matrix

Mesenchymal stem cells (MSC) show a very short proliferative life span and readily lose the differentiation potential in culture. However, the growth rate and the proliferative life span of the stem cells markedly increased using tissue culture dishes coated with a basement membrane-like extracellular matrix, which was produced by PYS-2 cells or primary endothelial cells. Furthermore, the stem cells expanded on the extracellular matrix, but not those on plastic tissue culture dishes, retained the osteogenic, chondrogenic, and adipogenic potential throughout many mitotic divisions. The extracellular matrix had greater effects on the proliferation of MSC and the maintenance of the multi-lineage differentiation potential than basic fibroblast growth factor. Mesenchymal stem cells expanded on the extracellular matrix should be useful for regeneration of large tissue defects and repeated cell therapies, which require a large number of stem or progenitor cells.     

整合素BmIntegrin β2的结构分析及其对家蚕血细胞的调控作用

整合素是一类广泛分布于细胞表面的黏附分子受体,是由α和β两个亚基组成的异源二聚体跨膜蛋白,其是细胞内外信号转导的中间桥梁。在鳞翅目昆虫细胞内,整合素主要表达于血细胞,参与昆虫细胞免疫反应进程。文中首先通过RACE技术等,克隆获得BmIntegrin β2基因cDNA全长序列2 434 bp;并对其蛋白结构域进行了预测,主要包括信号肽、一段较大的胞外域,单次跨膜结构和较短的胞内域;利用qRT-PCR技术检测了家蚕4龄3天和5龄3天的BmIntegrin β2各组织表达图谱,结果显示其主要在血细胞和造血器官中高表达;然后再经原核诱导表达、蛋白纯化及免疫动物后获得BmIntegrin β2抗体。通过对BmIntegrin β2蛋白功能作用的研究发现,BmIntegrin β2抗体可显著地减少浆细胞的数量,这从侧面说明BmIntegrin β2抗体可能抑制了浆细胞的延伸性和粘附能力。该结果不仅为BmIntegrin β2参与家蚕细胞的免疫反应奠定了基础,还提供了一个新的研究视野。     

家蚕CRISPR/Cpf1基因编辑系统建立

自CRISPR/Cas9基因编辑系统成功应用于模式生物以来,因其快速、高效、便捷等特点,广泛应用于基因功能研究、基因治疗和基因工程等研究领域。与此同时,CRISPR/Cas系统不断在微生物界的发现也加速了新的基因编辑工具的不断涌现。CRISPR/Cpf1是第二类 (Ⅴ型) 能够编辑哺乳动物基因组的CRISPR系统,相比于CRISPR/Cas9基因编辑系统,能够利用5′T-PAM富集区增加基因组覆盖率,具有其切割位点为粘性末端和更不易同源重组修复等诸多优势。基于此,本研究构建了能够在家蚕细胞表达的3个不同来源的CRISPR/Cpf1 (AsCpf1、FnCpf1和LbCpf1) 表达载体,选择高度保守的家蚕热休克蛋白基因BmHSP60和家蚕ATP酶家族BmATAD3A基因分别设计靶标gRNA,构建gHSP60-266R和gATAD3A-346R基因编辑载体。通过T7E1酶切分析和T克隆测序,鉴定3个Cpf1基因编辑系统AsCpf1、FnCpf1和LbCpf1对靶标基因BmHSP60和BmATAD3A的编辑效率。同时,利用Western blotting分析不同基因编辑系统敲除靶基因后对其BmATAD3A和BmHSP60蛋白翻译的影响。本研究成功构建了家蚕CRISPR/Cpf1基因编辑系统,能够在家蚕细胞中有效编辑家蚕基因组,为家蚕基因功能研究、基因工程和遗传育种开发了新技术与新方法。